<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>13</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Cytotoxic Effects of Dimethylamino Parthenolide on the Rheumatoid Arthritis Fibroblast-Like Synoviocytes Cell Line</title>
	<subject_fa>ايمونولوژي</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>گزارش کوتاه</content_type_fa>
	<content_type>Short Communication</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt; Rheumatoid arthritis&lt;b&gt; &lt;/b&gt;(RA) is a chronic inflammatory autoimmune disease in which &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;fibroblast-like synoviocytes (FLS) play a critical role in its pathogenesis. Due to the significant side effects associated with conventional treatments and the lack of response to the therapy in some patients, researchers are investigating novel therapeutic approaches that offer improved efficacy and a more favorable safety profile. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;This study aimed to investigate the cytotoxic activity of dimethylamino parthenolide (DMAPT) on the &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) cell line.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;Methods:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt; For this purpose, the RA-FLS cell line, previously generated in our unpublished studies, was treated with varying concentrations of DMAPT (0-160 &amp;mu;M) for 24 and 48 hours. Cell viability was assessed using the MTT assay. The half-maximal inhibitory concentration (IC&lt;/span&gt;&lt;span cambria=&quot;&quot; math=&quot;&quot; style=&quot;font-family:&quot;&gt;₅₀&lt;/span&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;) values were derived from dose-response curves fitted using GraphPad Prism software (version&lt;/span&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;Results: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;Our results demonstrated that DMAPT exerts cytotoxic effects on the RA-FLS cell line, leading to a significant reduction in cell viability. This cytotoxic effect is dose-dependent, such that cell viability decreased with increasing dose. The half-maximal inhibitory concentration (IC&lt;/span&gt; &lt;span cambria=&quot;&quot; math=&quot;&quot; style=&quot;font-family:&quot;&gt;₅₀&lt;/span&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;) values of DMAPT for rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) were 51.02 &amp;mu;M at 24 hours and 45.8 &amp;mu;M at 48 hours.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#1d1d1d&quot;&gt;Our results demonstrated that DMAPT exerts cytotoxic effects on rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Dimethylamino Parthenolide, DMAPT, Rheumatoid Arthritis, RAFLS, FLS, Fibroblast-Like Synoviocytes</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-1465-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sara</first_name>
	<middle_name></middle_name>
	<last_name>Sadeqi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Sadeqisara390@yahoo.com</email>
	<code>100319475328460013513</code>
	<orcid>100319475328460013513</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology and Microbiology, Sari Medical School, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Yazdani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zahrayazdanikachooi1391@gmail.com</email>
	<code>100319475328460013514</code>
	<orcid>100319475328460013514</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology and Microbiology, Sari Medical School, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Parisa</first_name>
	<middle_name></middle_name>
	<last_name>Zafari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>pzafari.70@gmail.com</email>
	<code>100319475328460013515</code>
	<orcid>100319475328460013515</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, School of Medicine, Hamedan University of Medical Sciences, Hamedan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Salman</first_name>
	<middle_name></middle_name>
	<last_name>Ghafari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>salmanghafari@gmail.com</email>
	<code>100319475328460013516</code>
	<orcid>100319475328460013516</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Orthopedic Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza</first_name>
	<middle_name></middle_name>
	<last_name>Rafiei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rafiei1710@gmail.com</email>
	<code>100319475328460013517</code>
	<orcid>100319475328460013517</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Immunology and Microbiology, Sari Medical School, Mazandaran University of Medical Sciences, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
